Big Pharma allows millions of people to alleviate debilitating pain, manage dangerous and chronic diseases, mitigate their ...
GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...
In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.90. The company’s shares opened today at ...
Stock selection in the information technology, financials, consumer discretionary and communication services sectors drove ...
The World Bank’s ‘one stop shop’ bid to up investment. Plus, we list down the Inter-American Development Bank's top 10 ...
Dan O’Day drives Gilead's mission to end HIV worldwide, pioneering treatments like lenacapavir and championing global health ...
Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that ...
In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.
New research led by the University of Washington found that wildfire smoke is especially hazardous to people's memory health. An analysis of the health care records of 1.2 million Southern California ...
A novel asthma burden score that incorporated asthma exacerbations and healthcare utilization better reflected disease ...
US health officials have approved vaccines for respiratory syncytial virus (RSV), an infection that can be deadly for some ...
The global over-the-counter (OTC) pain medication market is poised for steady growth, with its market size expected to attain ...